Global drug safety solutions and pharmacovigilance market is projected to register a substantial CAGR of 7.4% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation:
By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Some of the major factors contributing to the growth of the market are:
- Increasing health care expenditure
- Increasing number of pipeline products for treatment of various diseases
Market Players:
The key market players for global drug safety solutions and pharmacovigilance market are listed below:
- Pharmaceutical Product Development, LLC
- Drug Safety Solutions Limited
- C3i
- Worldwide Clinical Trials
- Bioclinica
- United Biosource LLC
- Ennov
- AB Cube
- Covance Inc.
- Accenture
- PRA Health Sciences, Inc.
- Ergomed
- IQVIA
- Genpact
- Cognizant
- Parexel International Corporation
- ArisGlobal
- ICON plc
- Oracle
- Syneos Health